Drug · DIN 02491575
JINARC
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 26, 2020; first marketed March 26, 2020.
- Drug Identification Number (DIN)
- 02491575
- Company (DIN owner)
- Otsuka Pharmaceutical Co LtdChiyoda-Ku Tokyo, Japan
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Tolvaptan C03XA01
- Class
- Human
- Record last updated
- September 10, 2026
Active ingredients
As listed in the Drug Product Database.
Notices of Compliance
Health Canada approvals that name this DIN.
- August 16, 2019: NOC 22549Supplement to a New Drug Submission (SNDS) · To add two new combinations (15mg + 15mg, 30mg + 15mg) to the existing product line.
Other DINs named JINARC
- DIN 02437503 · Marketed
- DIN 02437511 · Marketed
- DIN 02437538 · Marketed
- DIN 02491583 · Marketed